Clinical Impact of New Viral Hepatitis Data From AASLD 2022*

Download All
November 4-8, 2022; Washington, DC
Get up to date on the latest practice-changing viral hepatitis data presented at AASLD 2022. Review key studies on HBV, HCV, and HDV; view on-demand webcasts; listen to the on-demand podcasts; download the slides; and read expert commentaries.
Nancy Reau, MD
Stefan Zeuzem, MD


Read expert faculty members’ summaries of HBV, HDV, and HCV studies, including data on HBV therapy during pregnancy, HBV therapeutic vaccines and progress toward an HBV cure, HDV clinical impact and phase III clinical trial updates, and HCV implementation science and current status of the cascade of care.

Nancy Reau, MD Stefan Zeuzem, MD Released: November 16, 2022
Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie Inc.
Gilead Sciences, Inc.

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings